PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

BOSTON --(BUSINESS WIRE)--Oct. 2, 2025-- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that the Company’s